Pharmascience | Leadership in the Pharmaceutical Industry

Our Leadership

Competence & Dedication at the Helm

Our team of dedicated leaders strive everyday to improve the health and wellbeing of our patients, our customers, and our communities across the globe. We are committed to providing high-quality, affordable medication and the highest level of customer service.

Co-Founder & Chairman Emeritus

Morris Goodman, B.Ph, LL.D

As a pioneer and leading entrepreneur in the Canadian generic drug industry, Mr. Morris Goodman has dedicated his career to creating a difference in global healthcare.

After graduating from the University of Montreal’s Faculty of Pharmacy in 1953, Mr. Goodman co-founded his first company, Winley-Morris. In 1971, he sold Winley-Morris to the International Chemical & Nuclear Corporation (ICN) and continued to serve as the President of ICN Canada until 1983.

A Leader and a Visionary

With a determination to transform the Canadian pharmaceutical industry through innovation and R&D, Mr. Goodman co-founded Pharmascience in 1983 with trusted friend and fellow pharmacist Ted Wise. Mr. Goodman’s leadership and vision piloted Pharmascience to the forefront of this industry to become one of the top generic pharmaceutical manufacturers in Canada.

Today, he continues to be an active leader at Pharmascience, serving as Chairman of the Board.

A Passionate Philanthropist

Mr. Goodman is a passionate philanthropist, devotedly giving back to the community through The Morris & Rosalind Goodman Family Foundation, notably with The Stroke Unit at the Jewish General Hospital of Montreal, the Faculty of Pharmacy and Outremont Campus at the University of Montreal, CHU Sainte-Justine’s Goodman Pediatric Formulations Centre, and The Rosalind & Morris Goodman Cancer Research Centre at McGill University.

For more information on The Morris & Rosalind Goodman Family Foundation philanthropic activities, click here.

Executive Chairman of the Board

David Goodman, Ph.D.

Growth and Success

Dr. David Goodman was Chief Executive Officer of Pharmascience Inc. from 2006 to 2022. Prior to this nomination, he was Executive Vice President of Pharmascience International. He started his career at Pharmascience in Business Development before taking successively senior domestic and international roles. His business acumen, leadership skills and innovative vision have allowed Pharmascience to expand into a tier-1 Canadian Pharmaceutical company with both branded and generic products, including significant international operations in growth regions. His focus on investing in R&D programs, fostering a culture of continuous innovation and meeting customers’ needs have been pillars of his leadership.

Innovator and Entrepreneur

Dr. Goodman is involved in innovation inside and outside Pharmascience. He currently serves as a board member on several private companies such as Bion Pharma (Princeton, NJ) and is involved in many entrepreneurial activities. He also served as an advisor to a number of private equity funds.

Dr. Goodman holds a Bachelor’s degree of Commerce from McGill University and a Ph.D. in Pharmacology from the University of Virginia.

Continuing the Philanthropic Legacy

Dr. Goodman continues the company’s strong philanthropic legacy with Centraide, and other organizations which the company supports through various employee and industry initiatives. He serves on the boards of the Rosalind and Morris Goodman Cancer Institute at McGill University, Centraide of Greater Montreal, as well as the President’s Advisory Committee for the Jewish General Hospital Board of Directors.

Chief Executive Officer

Martin Arès

Martin Arès

Martin Arès is Chief Executive Officer of Pharmascience since the beginning of 2023.

An experienced leader in the pharmaceutical industry, he is recognized for his strategic vision and his collaborative and inspiring approach that brings teams together to achieve common goals. He has extensive professional experience in Canada, the United States and Europe with leading global pharmaceutical companies. He also has broad expertise in the biosimilars and generics industry.

Through his various past experiences, Mr. Arès has brought to the forefront his expertise in innovative strategic direction, product portfolio management, strategic investments, and operational execution, allowing companies to evolve in a spirit of constant growth.

A 360 experience

Over the years, he has developed strong experience and leadership in many commercial and global roles with high levels of complexity, where strong collaboration with commercial, research, quality, production, and supply chain teams was essential for success.

A human-centred vision

Throughout his career, Mr. Arès has always been committed to a customer-focused approach, employee development and the mission of improving access to medicines for all, while supporting the sustainability of the supply chain. At Pharmascience, he wants to leverage his global knowledge of the pharmaceutical environment, as well as his collaborative approach with employees, to fulfill this mission.

A Dedicated Team

Martin Beaudry, MBA

Vice President, Information Technologies

Alain Carrier

Vice President, Scientific Affairs

Mike Dutton

Vice President & General Manager, Pharmascience Canada

Paul J. Evans

Vice President, Global Business Development & Portfolio

John Foy, MBA, B.S.

General Manager, CDMO

Jacquelin Gagnon, BBA

Vice President & General Manager, Pharmascience International

Sonia Girolamo, CPA, CA

Vice President Finance & Chief Financial Officer

Sean Globe

Vice President, Global Supply Chain

Jad Isber B. Eng, MBA

Vice President & General Manager, Pendopharm

Irene Mascolo, MBA

Vice President, Human Resources & Communications

Mohamed Mostafa

Executive Vice President, Operations & Supply Chain

Gregory Orleski, B.A., B.C.L., LL.B.

Vice President, Legal Affairs, General Counsel & Corporate Secretary

Samba Sow, PharmD, MBA

Vice President, Quality & Compliance

Got the right chemistry to join our team?